SEC Form 4 · accession 0001177648-17-000022
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul J Mellett
Officer — Treasurer and CFO
Period of report
Apr 11, 2017
Accepted (ET)
Apr 12, 2017 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 11, 2017 | M | 29,274 | $2.9739 | A | 91,979 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.9739 | Apr 11, 2017 | M | 29,274 | D | — | Jul 12, 2017 | Common Stock | 29,274 | 0 | D |
Explanation of responses
- F1100% of the shares subject to the option are fully vested and exercisable.